Amphastar Pharmaceuticals Other Non-Current Liabilities 2012-2024 | AMPH
Amphastar Pharmaceuticals other non-current liabilities from 2012 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Amphastar Pharmaceuticals Annual Other Non-Current Liabilities
(Millions of US $) |
| 2023 |
$29 |
| 2022 |
$22 |
| 2021 |
$22 |
| 2020 |
$18 |
| 2019 |
$13 |
| 2018 |
$9 |
| 2017 |
$8 |
| 2016 |
$4 |
| 2015 |
$3 |
| 2014 |
$1 |
| 2013 |
$2 |
| 2012 |
$2 |
| 2011 |
$ |
| 2009 |
$ |
Amphastar Pharmaceuticals Quarterly Other Non-Current Liabilities
(Millions of US $) |
| 2024-09-30 |
$33 |
| 2024-06-30 |
$25 |
| 2024-03-31 |
$24 |
| 2023-12-31 |
$29 |
| 2023-09-30 |
$23 |
| 2023-06-30 |
$25 |
| 2023-03-31 |
$22 |
| 2022-12-31 |
$22 |
| 2022-09-30 |
$21 |
| 2022-06-30 |
$22 |
| 2022-03-31 |
$22 |
| 2021-12-31 |
$22 |
| 2021-09-30 |
$20 |
| 2021-06-30 |
$18 |
| 2021-03-31 |
$18 |
| 2020-12-31 |
$18 |
| 2020-09-30 |
$15 |
| 2020-06-30 |
$14 |
| 2020-03-31 |
$14 |
| 2019-12-31 |
$13 |
| 2019-09-30 |
$9 |
| 2019-06-30 |
$9 |
| 2019-03-31 |
$9 |
| 2018-12-31 |
$9 |
| 2018-09-30 |
$9 |
| 2018-06-30 |
$9 |
| 2018-03-31 |
$9 |
| 2017-12-31 |
$8 |
| 2017-09-30 |
$5 |
| 2017-06-30 |
$5 |
| 2017-03-31 |
$4 |
| 2016-12-31 |
$4 |
| 2016-09-30 |
$4 |
| 2016-06-30 |
$4 |
| 2016-03-31 |
$3 |
| 2015-12-31 |
$3 |
| 2015-09-30 |
$2 |
| 2015-06-30 |
$2 |
| 2015-03-31 |
$2 |
| 2014-12-31 |
$1 |
| 2014-09-30 |
$1 |
| 2014-06-30 |
$1 |
| 2014-03-31 |
$2 |
| 2013-12-31 |
$2 |
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
$2 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.142B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
